Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; Red, flushing with pain and numbness in hands and feet, drop in BP dizziness, and bad taste in mouth and loss of hearing right ear; This is a spontaneous report from a contactable other hcp (Patient). A 44-years-old Non- Pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW167 and Expiry date was not reported), via an intramuscular route of administration on 18Aug2021 15:30 (at the age of 44-years-old) in Arm Right as dose number unknown, single for COVID-19 immunization. The Patient Medical history included hypertension, diabetes mellitus, asthma from all an unknown date and unknown if ongoing , drug hypersensitivity (Known allergies: sulfa) and COVID-19 from an unknown date and unknown if ongoing If covid prior vaccination:Yes. Concomitant medication(s) included fluticasone propionate, salmeterol xinafoate (ADVAIR), BP medication and diabetic med all taken for an unspecified indication, start and stop date were not reported. The patient received other medications within 2 weeks of vaccination: BP medication and diabetic med and advair inhaler. The Patient was not pregnant at the time of vaccination. The patient had not received other vaccine in 4 weeks prior to COVID 19. The Patient diagnosed with COVID-19 prior to vaccination and the patient had tested for COVID-19 post vaccination. On 19Aug2021 16:00, the patient experienced red, flushing with pain and numbness in hands and feet, drop in bp dizziness, and bad taste in mouth and loss of hearing right ear. The Patient received treatment with steroids. Patient visited physician office. The patient underwent lab tests and procedures which included blood pressure measurement: drop in bp on 19Aug2021, sars-cov-2 test: unknown on 23Aug2021 Nasal Swab. The outcome for the events was recovered with sequel in 2021.     No follow-up attempts are possible. No further information is expected.; Sender's Comments: The event of "deafness unilateral" is assessed as possibly related to the suspect drug "BNT162B2" based on strong temporal association, but consider also possible contributory effects from patient's medical history and/or concomitant medications. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.